Concepts (289)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Islets of Langerhans | 24 | 2020 | 74 | 6.230 |
Why?
|
| Islets of Langerhans Transplantation | 19 | 2017 | 40 | 5.600 |
Why?
|
| Alginates | 27 | 2017 | 49 | 4.980 |
Why?
|
| Cells, Immobilized | 9 | 2017 | 23 | 3.790 |
Why?
|
| Drug Compounding | 11 | 2017 | 36 | 2.560 |
Why?
|
| Tissue Engineering | 12 | 2020 | 608 | 2.090 |
Why?
|
| Capsules | 7 | 2017 | 14 | 1.730 |
Why?
|
| Cell Separation | 4 | 2017 | 86 | 1.730 |
Why?
|
| Diabetes Mellitus, Type 1 | 6 | 2017 | 180 | 1.720 |
Why?
|
| Ovary | 3 | 2017 | 54 | 1.630 |
Why?
|
| Omentum | 7 | 2017 | 26 | 1.550 |
Why?
|
| Pancreas | 7 | 2020 | 79 | 1.510 |
Why?
|
| Granulosa Cells | 3 | 2019 | 11 | 1.490 |
Why?
|
| Hexuronic Acids | 22 | 2017 | 31 | 1.460 |
Why?
|
| Glucuronic Acid | 22 | 2017 | 31 | 1.460 |
Why?
|
| Hormone Replacement Therapy | 3 | 2019 | 86 | 1.420 |
Why?
|
| Microspheres | 15 | 2017 | 37 | 1.400 |
Why?
|
| Animals | 43 | 2019 | 7297 | 1.400 |
Why?
|
| Antioxidants | 7 | 2006 | 114 | 1.270 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2017 | 51 | 1.190 |
Why?
|
| Oxygen | 2 | 2017 | 139 | 1.140 |
Why?
|
| Pancreas, Artificial | 3 | 2013 | 4 | 1.130 |
Why?
|
| Theca Cells | 3 | 2019 | 9 | 1.020 |
Why?
|
| Peptides | 5 | 2017 | 118 | 1.020 |
Why?
|
| Cell Culture Techniques | 4 | 2017 | 165 | 0.960 |
Why?
|
| Regenerative Medicine | 4 | 2013 | 187 | 0.920 |
Why?
|
| Biocompatible Materials | 6 | 2017 | 210 | 0.900 |
Why?
|
| Insulin-Secreting Cells | 3 | 2020 | 53 | 0.800 |
Why?
|
| Estrogens | 2 | 2019 | 162 | 0.790 |
Why?
|
| Osmotic Pressure | 3 | 2018 | 9 | 0.790 |
Why?
|
| Neovascularization, Physiologic | 7 | 2017 | 106 | 0.740 |
Why?
|
| Cross-Linking Reagents | 3 | 2017 | 16 | 0.710 |
Why?
|
| Polylysine | 2 | 2017 | 5 | 0.700 |
Why?
|
| Tissue Scaffolds | 5 | 2020 | 386 | 0.690 |
Why?
|
| Drug Delivery Systems | 4 | 2017 | 92 | 0.690 |
Why?
|
| Stress, Mechanical | 2 | 2017 | 90 | 0.650 |
Why?
|
| Fibroblast Growth Factor 1 | 7 | 2014 | 9 | 0.640 |
Why?
|
| Coculture Techniques | 3 | 2017 | 74 | 0.640 |
Why?
|
| Bioartificial Organs | 1 | 2017 | 25 | 0.630 |
Why?
|
| Cell Transplantation | 4 | 2017 | 63 | 0.620 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2019 | 161 | 0.620 |
Why?
|
| Polymers | 2 | 2017 | 59 | 0.610 |
Why?
|
| Diabetes Mellitus | 2 | 2016 | 366 | 0.600 |
Why?
|
| Carbonates | 1 | 2017 | 3 | 0.600 |
Why?
|
| Polyamines | 1 | 2017 | 10 | 0.590 |
Why?
|
| Peroxides | 1 | 2017 | 31 | 0.590 |
Why?
|
| Rats, Inbred F344 | 4 | 2019 | 125 | 0.580 |
Why?
|
| Graft Survival | 2 | 2017 | 228 | 0.580 |
Why?
|
| Rats | 14 | 2017 | 1604 | 0.570 |
Why?
|
| Cell Survival | 7 | 2018 | 272 | 0.540 |
Why?
|
| Glutathione | 3 | 2006 | 37 | 0.520 |
Why?
|
| Oxidative Stress | 3 | 2006 | 223 | 0.520 |
Why?
|
| Humans | 31 | 2020 | 29093 | 0.510 |
Why?
|
| Immunocompetence | 1 | 2014 | 12 | 0.500 |
Why?
|
| Cells, Cultured | 6 | 2019 | 799 | 0.490 |
Why?
|
| Female Urogenital Diseases | 1 | 2013 | 4 | 0.480 |
Why?
|
| Urogenital System | 1 | 2013 | 9 | 0.480 |
Why?
|
| Insulin | 5 | 2017 | 346 | 0.470 |
Why?
|
| Gonadotropins | 1 | 2012 | 5 | 0.450 |
Why?
|
| Biopolymers | 1 | 2013 | 4 | 0.450 |
Why?
|
| Peptide Hormones | 1 | 2012 | 11 | 0.450 |
Why?
|
| Artificial Organs | 1 | 2013 | 12 | 0.450 |
Why?
|
| Steroids | 1 | 2012 | 36 | 0.440 |
Why?
|
| Blood Glucose | 5 | 2017 | 466 | 0.400 |
Why?
|
| Extracellular Matrix | 3 | 2020 | 226 | 0.390 |
Why?
|
| Particle Size | 5 | 2017 | 42 | 0.380 |
Why?
|
| Epithelial Cells | 3 | 2017 | 138 | 0.380 |
Why?
|
| Gels | 2 | 2006 | 33 | 0.360 |
Why?
|
| Lipid Peroxides | 3 | 2004 | 8 | 0.350 |
Why?
|
| Micronutrients | 2 | 2006 | 15 | 0.350 |
Why?
|
| Mice | 7 | 2017 | 2368 | 0.340 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2005 | 17 | 0.330 |
Why?
|
| Uterus | 2 | 2019 | 73 | 0.320 |
Why?
|
| Gastrointestinal Tract | 3 | 2012 | 29 | 0.300 |
Why?
|
| Cell Differentiation | 4 | 2017 | 436 | 0.300 |
Why?
|
| Delayed-Action Preparations | 5 | 2017 | 35 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2017 | 747 | 0.300 |
Why?
|
| Viscosity | 3 | 2017 | 21 | 0.290 |
Why?
|
| Rats, Inbred Lew | 6 | 2016 | 116 | 0.290 |
Why?
|
| Gastric Emptying | 2 | 2005 | 4 | 0.290 |
Why?
|
| Trans-Activators | 2 | 2017 | 47 | 0.290 |
Why?
|
| Homeodomain Proteins | 2 | 2017 | 50 | 0.290 |
Why?
|
| Amnion | 2 | 2017 | 36 | 0.280 |
Why?
|
| Dietary Supplements | 2 | 2006 | 170 | 0.280 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2006 | 23 | 0.280 |
Why?
|
| Swine | 4 | 2017 | 201 | 0.280 |
Why?
|
| Female | 10 | 2019 | 18164 | 0.270 |
Why?
|
| Indomethacin | 1 | 2005 | 6 | 0.260 |
Why?
|
| Stomach Diseases | 1 | 2005 | 7 | 0.260 |
Why?
|
| Proton Pump Inhibitors | 1 | 2004 | 11 | 0.250 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 71 | 0.250 |
Why?
|
| Povidone | 1 | 2004 | 1 | 0.240 |
Why?
|
| Cryoprotective Agents | 1 | 2004 | 5 | 0.240 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2014 | 15 | 0.240 |
Why?
|
| Glycemic Index | 1 | 2004 | 14 | 0.240 |
Why?
|
| Postural Balance | 1 | 2016 | 160 | 0.240 |
Why?
|
| Cryopreservation | 1 | 2004 | 42 | 0.240 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 162 | 0.240 |
Why?
|
| Denervation | 1 | 2003 | 13 | 0.230 |
Why?
|
| Pesticides | 1 | 2016 | 189 | 0.230 |
Why?
|
| Intestine, Small | 1 | 2003 | 34 | 0.230 |
Why?
|
| Occupational Exposure | 1 | 2016 | 224 | 0.230 |
Why?
|
| Omeprazole | 1 | 2002 | 1 | 0.230 |
Why?
|
| Gastric Mucosa | 1 | 2002 | 12 | 0.220 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 235 | 0.220 |
Why?
|
| Ascorbic Acid | 1 | 2002 | 21 | 0.220 |
Why?
|
| Transients and Migrants | 1 | 2016 | 281 | 0.220 |
Why?
|
| Time Factors | 5 | 2014 | 2001 | 0.210 |
Why?
|
| Organ Transplantation | 2 | 2012 | 65 | 0.190 |
Why?
|
| Aromatase | 1 | 2019 | 6 | 0.180 |
Why?
|
| Luteinizing Hormone | 1 | 2019 | 18 | 0.180 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2019 | 19 | 0.180 |
Why?
|
| Cell Proliferation | 3 | 2016 | 573 | 0.180 |
Why?
|
| Microscopy, Confocal | 2 | 2017 | 62 | 0.180 |
Why?
|
| Hispanic Americans | 1 | 2016 | 904 | 0.180 |
Why?
|
| Progesterone | 1 | 2019 | 80 | 0.170 |
Why?
|
| Pancreas Transplantation | 2 | 2017 | 80 | 0.170 |
Why?
|
| Ovariectomy | 1 | 2019 | 147 | 0.170 |
Why?
|
| Male | 9 | 2018 | 17807 | 0.170 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2018 | 1 | 0.170 |
Why?
|
| Strontium | 1 | 2017 | 5 | 0.160 |
Why?
|
| Osteocalcin | 1 | 2017 | 9 | 0.160 |
Why?
|
| Rats, Wistar | 2 | 2016 | 84 | 0.160 |
Why?
|
| Hormones | 1 | 2017 | 19 | 0.160 |
Why?
|
| Activins | 1 | 2017 | 3 | 0.150 |
Why?
|
| Niacinamide | 1 | 2017 | 8 | 0.150 |
Why?
|
| Muscle Development | 1 | 2017 | 45 | 0.150 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 80 | 0.150 |
Why?
|
| Permeability | 1 | 2017 | 9 | 0.150 |
Why?
|
| Cations | 1 | 2017 | 9 | 0.150 |
Why?
|
| Probiotics | 1 | 2017 | 8 | 0.150 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2016 | 9 | 0.150 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2017 | 16 | 0.150 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2017 | 64 | 0.150 |
Why?
|
| Compressive Strength | 1 | 2017 | 20 | 0.150 |
Why?
|
| Thyroxine | 1 | 2016 | 16 | 0.150 |
Why?
|
| Cell Hypoxia | 1 | 2017 | 39 | 0.150 |
Why?
|
| Thyroid Gland | 1 | 2016 | 13 | 0.150 |
Why?
|
| Hypothyroidism | 1 | 2016 | 12 | 0.150 |
Why?
|
| Pancreatectomy | 1 | 2017 | 29 | 0.150 |
Why?
|
| Bacteria | 1 | 2017 | 45 | 0.140 |
Why?
|
| Foreign Bodies | 1 | 2016 | 29 | 0.140 |
Why?
|
| Urethra | 1 | 2017 | 100 | 0.140 |
Why?
|
| Awards and Prizes | 1 | 2016 | 11 | 0.140 |
Why?
|
| Drug Carriers | 2 | 2013 | 16 | 0.140 |
Why?
|
| Glucose | 3 | 2018 | 163 | 0.140 |
Why?
|
| Epidermal Growth Factor | 1 | 2016 | 21 | 0.140 |
Why?
|
| Bone Density | 1 | 2017 | 182 | 0.140 |
Why?
|
| Models, Biological | 2 | 2016 | 373 | 0.140 |
Why?
|
| Organoids | 1 | 2016 | 68 | 0.140 |
Why?
|
| Calcium | 1 | 2017 | 296 | 0.140 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 29 | 0.140 |
Why?
|
| History, 21st Century | 1 | 2016 | 48 | 0.140 |
Why?
|
| Flow Cytometry | 2 | 2013 | 171 | 0.140 |
Why?
|
| History, 20th Century | 1 | 2016 | 68 | 0.140 |
Why?
|
| Lipid Peroxidation | 2 | 2006 | 34 | 0.140 |
Why?
|
| Bioengineering | 2 | 2013 | 67 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2004 | 1379 | 0.130 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 242 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2016 | 190 | 0.130 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 176 | 0.120 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 167 | 0.120 |
Why?
|
| Angiogenic Proteins | 2 | 2010 | 9 | 0.120 |
Why?
|
| Mice, Inbred Strains | 2 | 2004 | 43 | 0.120 |
Why?
|
| Urodynamics | 1 | 2013 | 34 | 0.120 |
Why?
|
| Cell Communication | 1 | 2013 | 30 | 0.120 |
Why?
|
| Stromal Cells | 1 | 2013 | 70 | 0.110 |
Why?
|
| Bone Marrow | 1 | 2013 | 60 | 0.110 |
Why?
|
| Endocrine Cells | 1 | 2012 | 3 | 0.110 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2013 | 75 | 0.110 |
Why?
|
| Stem Cells | 2 | 2012 | 292 | 0.110 |
Why?
|
| Parkinson Disease | 1 | 2013 | 68 | 0.110 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2012 | 9 | 0.110 |
Why?
|
| Blood Vessels | 2 | 2010 | 47 | 0.110 |
Why?
|
| Urine | 1 | 2012 | 59 | 0.110 |
Why?
|
| Graft Rejection | 1 | 2013 | 149 | 0.110 |
Why?
|
| Immunosuppression | 1 | 2012 | 80 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 100 | 0.100 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 104 | 0.100 |
Why?
|
| General Surgery | 1 | 2012 | 81 | 0.100 |
Why?
|
| Cell Membrane | 1 | 2010 | 97 | 0.090 |
Why?
|
| Neoplasms | 1 | 2017 | 610 | 0.090 |
Why?
|
| Adipogenesis | 1 | 2010 | 26 | 0.090 |
Why?
|
| Materials Testing | 2 | 2010 | 84 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2010 | 131 | 0.090 |
Why?
|
| Capillaries | 1 | 2009 | 23 | 0.090 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 519 | 0.090 |
Why?
|
| Cytokines | 1 | 2010 | 243 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 441 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2016 | 3099 | 0.080 |
Why?
|
| Models, Animal | 2 | 2009 | 160 | 0.070 |
Why?
|
| Actins | 3 | 2013 | 52 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2010 | 327 | 0.070 |
Why?
|
| Liver Transplantation | 3 | 2012 | 111 | 0.070 |
Why?
|
| X-Ray Microtomography | 2 | 2016 | 40 | 0.070 |
Why?
|
| Trace Elements | 1 | 2006 | 7 | 0.070 |
Why?
|
| Flavonoids | 1 | 2006 | 18 | 0.070 |
Why?
|
| Phenols | 1 | 2006 | 16 | 0.070 |
Why?
|
| Gastrointestinal Diseases | 1 | 2006 | 38 | 0.070 |
Why?
|
| Porosity | 1 | 2005 | 36 | 0.070 |
Why?
|
| Elasticity | 1 | 2005 | 34 | 0.070 |
Why?
|
| Tensile Strength | 1 | 2005 | 52 | 0.070 |
Why?
|
| Vitamins | 1 | 2006 | 58 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 158 | 0.070 |
Why?
|
| Mice, Inbred A | 1 | 2005 | 4 | 0.070 |
Why?
|
| Peroxidase | 1 | 2005 | 33 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 980 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2004 | 47 | 0.060 |
Why?
|
| Equipment Design | 2 | 2017 | 167 | 0.060 |
Why?
|
| Fatty Liver | 1 | 2004 | 66 | 0.060 |
Why?
|
| Pharmaceutic Aids | 1 | 2004 | 1 | 0.060 |
Why?
|
| Nitrogen | 1 | 2004 | 6 | 0.060 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2004 | 10 | 0.060 |
Why?
|
| Glycerol | 1 | 2004 | 5 | 0.060 |
Why?
|
| Cytoskeleton | 1 | 2004 | 16 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 66 | 0.060 |
Why?
|
| Temperature | 1 | 2004 | 55 | 0.060 |
Why?
|
| Rats, Inbred ACI | 1 | 2003 | 5 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2016 | 859 | 0.060 |
Why?
|
| Ileum | 1 | 2003 | 13 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 641 | 0.050 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2002 | 3 | 0.050 |
Why?
|
| Receptors, Prolactin | 1 | 2002 | 1 | 0.050 |
Why?
|
| Regeneration | 2 | 2016 | 167 | 0.050 |
Why?
|
| North Carolina | 1 | 2016 | 1423 | 0.050 |
Why?
|
| Solubility | 1 | 2020 | 38 | 0.050 |
Why?
|
| Endothelial Cells | 2 | 2013 | 179 | 0.050 |
Why?
|
| Cell Death | 1 | 2018 | 71 | 0.040 |
Why?
|
| Dogs | 1 | 2018 | 117 | 0.040 |
Why?
|
| Adult | 2 | 2016 | 8420 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2017 | 21 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2012 | 369 | 0.040 |
Why?
|
| Rats, Inbred WF | 1 | 2016 | 8 | 0.040 |
Why?
|
| Organogenesis | 1 | 2016 | 15 | 0.040 |
Why?
|
| Cell Count | 1 | 2016 | 50 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 42 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 68 | 0.030 |
Why?
|
| Macrophages | 1 | 2016 | 188 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 629 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2013 | 8 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2013 | 13 | 0.030 |
Why?
|
| Oxidopamine | 1 | 2013 | 6 | 0.030 |
Why?
|
| Substantia Nigra | 1 | 2013 | 11 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2013 | 31 | 0.030 |
Why?
|
| Cadherins | 1 | 2013 | 24 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2013 | 52 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2017 | 666 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 158 | 0.030 |
Why?
|
| Detergents | 1 | 2013 | 17 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 152 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2013 | 44 | 0.030 |
Why?
|
| Perfusion | 1 | 2013 | 64 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2013 | 71 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 494 | 0.030 |
Why?
|
| Nanocapsules | 1 | 2012 | 4 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 74 | 0.030 |
Why?
|
| Aged | 1 | 2016 | 9487 | 0.030 |
Why?
|
| Calcium Chloride | 1 | 2012 | 3 | 0.030 |
Why?
|
| Skin, Artificial | 1 | 2012 | 31 | 0.030 |
Why?
|
| Larynx | 1 | 2012 | 19 | 0.030 |
Why?
|
| Chondroitin Sulfates | 1 | 2012 | 22 | 0.030 |
Why?
|
| Respiratory Tract Diseases | 1 | 2012 | 30 | 0.030 |
Why?
|
| Middle Aged | 1 | 2016 | 10829 | 0.030 |
Why?
|
| Liver Diseases | 1 | 2012 | 61 | 0.030 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2012 | 78 | 0.030 |
Why?
|
| Corneal Transplantation | 1 | 2010 | 13 | 0.020 |
Why?
|
| Collagen | 1 | 2012 | 217 | 0.020 |
Why?
|
| Transplantation Immunology | 1 | 2010 | 27 | 0.020 |
Why?
|
| Transplants | 1 | 2010 | 22 | 0.020 |
Why?
|
| Wound Healing | 1 | 2012 | 182 | 0.020 |
Why?
|
| Proteins | 1 | 2012 | 140 | 0.020 |
Why?
|
| Intestines | 1 | 2010 | 54 | 0.020 |
Why?
|
| Trachea | 1 | 2010 | 55 | 0.020 |
Why?
|
| Heart | 1 | 2010 | 161 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2009 | 10 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 250 | 0.020 |
Why?
|
| Liver | 1 | 2010 | 464 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 2012 | 518 | 0.020 |
Why?
|
| Kidney | 1 | 2010 | 485 | 0.020 |
Why?
|
| Heart Failure | 1 | 2012 | 568 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2010 | 348 | 0.020 |
Why?
|
| Placental Lactogen | 1 | 2002 | 1 | 0.010 |
Why?
|
| Tissue Fixation | 1 | 2002 | 10 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 41 | 0.010 |
Why?
|
| Cell Size | 1 | 2002 | 32 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2002 | 125 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2002 | 425 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2002 | 514 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 711 | 0.010 |
Why?
|